Anjana Pillai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anjana Pillai has a total of 229 co-authors. Here are the top co-authors by number of shared publications:
- Elizabeth C. Verna
Center for Liver Disease and Transplantation, Columbia University, New York, New York, USA
4 shared publications - Neehar D. Parikh
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
4 shared publications - Elizabeth S. Aby
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
3 shared publications Jennifer Wang
Division of Gastroenterology and Hepatology Department of Internal Medicine Massachusetts General Hospital Boston MA USA
3 shared publications- Sonali Paul
Section of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, University of Chicago Medicine, Chicago, USA
3 shared publications - Alan L. Hutchison
University of Chicago
2 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published byĀ Wolters Kluwer HealthĀ inĀ ACG Case Reports Journal
- Vol.Ā 13 Ā (9)
Recurrent Sickle Cell Hepatopathy After Liver Transplantation Despite Guideline-Directed Red Blood Cell Exchange
Sickle cell hepatopathy is an uncommon but severe cause of liver dysfunction after transplantation. We present a case of a 37-year-old man who developed recurrent sickle cell hepatopathy 12 months postliver transplant despite maintaining hemoglobin S (HbS) levels below 30% per American Society of Hematology recommendations. Liver biopsy demonstrated sinusoidal sickling without rejection. Liver tests improved after intensifying red cell exchange to achieve HbS below 20%. This case illustrates that standard posttransplant HbS targets may be insufficient in high-risk patients and highlights the need for individualized HbS goals.
- 1 September 2026
- Published byĀ Wolters Kluwer HealthĀ inĀ ACG Case Reports Journal
- Vol.Ā 13 Ā (9)
Open AccessRecurrent Sickle Cell Hepatopathy After Liver Transplantation Despite Guideline-Directed Red Blood Cell Exchange
Sickle cell hepatopathy is an uncommon but severe cause of liver dysfunction after transplantation. We present a case of a 37-year-old man who developed recurrent sickle cell hepatopathy 12 months postliver transplant despite maintaining hemoglobin S (HbS) levels below 30% per American Society of Hematology recommendations. Liver biopsy demonstrated sinusoidal sickling without rejection. Liver tests improved after intensifying red cell exchange to achieve HbS below 20%. This case illustrates that standard posttransplant HbS targets may be insufficient in high-risk patients and highlights the need for individualized HbS goals.
- 23 April 2026
- Published byĀ Wolters Kluwer HealthĀ inĀ Transplantation
- Vol.Ā 110 Ā (5) , e965-e967
Institutional Strategies for Overcoming Academic Bullying, Rising Above Moral Injury, and Achieving Success
- 23 April 2026
- Published byĀ Wolters Kluwer HealthĀ inĀ Transplantation
- Vol.Ā 110 Ā (5) , e965-e967
Institutional Strategies for Overcoming Academic Bullying, Rising Above Moral Injury, and Achieving Success
- 9 April 2026
- Published byĀ Wolters Kluwer HealthĀ inĀ Transplantation
- Vol.Ā 110 Ā (5) , e958-e960
Current State of Gender Inequities in Transplantation Professionals Worldwide and Call for Prioritizing Gender Equity
Export
- 9 April 2026
- Published byĀ Wolters Kluwer HealthĀ inĀ Transplantation
- Vol.Ā 110 Ā (5) , e958-e960
Current State of Gender Inequities in Transplantation Professionals Worldwide and Call for Prioritizing Gender Equity
Export
- Open Access
- 13 May 2025
- Published byĀ ElsevierĀ inĀ American Journal of Transplantation
- Vol.Ā 25 Ā (8) , 1601-1613
Recommendations to overcome barriers to transplant fellowship training: A report from the American Society of Transplantation Fellows Task Force
- 13 May 2025
- Published byĀ ElsevierĀ inĀ American Journal of Transplantation
- Vol.Ā 25 Ā (8) , 1601-1613
Open AccessRecommendations to overcome barriers to transplant fellowship training: A report from the American Society of Transplantation Fellows Task Force
- 4 January 2025
- Published byĀ ElsevierĀ inĀ Gastroenterology
- Vol.Ā 168 Ā (4) , 650-651
Reimagining Liver Cancer Allocation: Defining a New Vision
- 4 January 2025
- Published byĀ ElsevierĀ inĀ Gastroenterology
- Vol.Ā 168 Ā (4) , 650-651
Reimagining Liver Cancer Allocation: Defining a New Vision
- 2 December 2024
- Published byĀ WileyĀ inĀ Clinical Transplantation
- Vol.Ā 38 Ā (12) , e70045
Influence of Acuity Circles on Hepatocellular Carcinoma and the Interaction of Gender and Race in Liver Transplantation
The impact of liver transplant allocation policy using acuity circles (ACs) on interactions between race and gender on waitlist mortality or receipt of deceased donor liver transplant (DDLT) is unknown. Using data from the United Network for Organ Sharing (UNOS), we examined adults listed for DDLT from April 3, 2017, to October 4, 2022 (30 months preā and postāAC). FineāGray subādistribution hazard model explored AC indicators by race and gender interactions and their effect on receipt of DDLT or waitlist mortality. Also explored was AC's impact on hepatocellular carcinoma (HCC) diagnosis and receipt of DDLT or waitlist mortality. 59 592 patients (30 202 preāAC, 29 390 postāAC) included. For both receipt of DDLT and waitlist mortality, there were no 3āway (AC by race by gender) interactions, indicating that the effects of race and gender on DDLT or waitlist mortality were consistent preā and postāAC. Irrespective of AC implementation, Black and Hispanic women were less likely to receive DDLT and had an increased risk of waitlist mortality compared to White women. White, Black, and Hispanic men had lower waitlist mortality risk and greater likelihood of receiving DDLT compared to their female race/ethnic counterparts. Patients with HCC had a significantly greater chance for DDLT than nonāHCC, although postāAC this effect was attenuated. Patients with HCC were also at greater risk of waitlist mortality preā and postāAC compared to those without HCC however, the waitlist mortality postāAC was attenuated only for those patients without HCC. To our knowledge, this is the first study to show the interaction of gender and race on waitlist mortality and access to transplantation since the implementation of AC, showing continued disparate outcomes for women both within and across racial groups.
- 2 December 2024
- Published byĀ WileyĀ inĀ Clinical Transplantation
- Vol.Ā 38 Ā (12) , e70045
Influence of Acuity Circles on Hepatocellular Carcinoma and the Interaction of Gender and Race in Liver Transplantation
The impact of liver transplant allocation policy using acuity circles (ACs) on interactions between race and gender on waitlist mortality or receipt of deceased donor liver transplant (DDLT) is unknown. Using data from the United Network for Organ Sharing (UNOS), we examined adults listed for DDLT from April 3, 2017, to October 4, 2022 (30 months preā and postāAC). FineāGray subādistribution hazard model explored AC indicators by race and gender interactions and their effect on receipt of DDLT or waitlist mortality. Also explored was AC's impact on hepatocellular carcinoma (HCC) diagnosis and receipt of DDLT or waitlist mortality. 59 592 patients (30 202 preāAC, 29 390 postāAC) included. For both receipt of DDLT and waitlist mortality, there were no 3āway (AC by race by gender) interactions, indicating that the effects of race and gender on DDLT or waitlist mortality were consistent preā and postāAC. Irrespective of AC implementation, Black and Hispanic women were less likely to receive DDLT and had an increased risk of waitlist mortality compared to White women. White, Black, and Hispanic men had lower waitlist mortality risk and greater likelihood of receiving DDLT compared to their female race/ethnic counterparts. Patients with HCC had a significantly greater chance for DDLT than nonāHCC, although postāAC this effect was attenuated. Patients with HCC were also at greater risk of waitlist mortality preā and postāAC compared to those without HCC however, the waitlist mortality postāAC was attenuated only for those patients without HCC. To our knowledge, this is the first study to show the interaction of gender and race on waitlist mortality and access to transplantation since the implementation of AC, showing continued disparate outcomes for women both within and across racial groups.
- 29 November 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ Liver Transplantation
- Vol.Ā 31 Ā (4) , 545-547
A history of transplant oncologyāThe story of Steve Jobs
An abstract is unavailable. This article is available as a PDF only.
- 29 November 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ Liver Transplantation
- Vol.Ā 31 Ā (4) , 545-547
A history of transplant oncologyāThe story of Steve Jobs
An abstract is unavailable. This article is available as a PDF only.
- 30 October 2024
- Published byĀ ElsevierĀ inĀ Clinics in Liver Disease
- Vol.Ā 29 Ā (1) , 1-15
The Changing Demographics and Epidemiology of Hepatocellular Carcinoma
- 30 October 2024
- Published byĀ ElsevierĀ inĀ Clinics in Liver Disease
- Vol.Ā 29 Ā (1) , 1-15
The Changing Demographics and Epidemiology of Hepatocellular Carcinoma
- 21 October 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Gastroenterology
- Vol.Ā 120 Ā (5) , 936-938
Focal Liver Lesions
An abstract is unavailable. This article is available as a PDF only.
- 21 October 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ American Journal of Gastroenterology
- Vol.Ā 120 Ā (5) , 936-938
Focal Liver Lesions
An abstract is unavailable. This article is available as a PDF only.
- 30 July 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ Hepatology
- Vol.Ā 83 Ā (5) , 1287-1302
The rise of multidisciplinary clinics in hepatology: A practical, how-to-guide, and review of the literature
Multidisciplinary clinics (MDCs) are gaining momentum throughout the medical field, having initially been pioneered in oncology clinics due to their inherent ability to streamline complex care and improve both patient outcomes and the patient care experience. Liver transplant and hepatobiliary tumor clinics are examples of established MDCs in hepatology. With the changing landscape of liver disease in regard to etiology and patient complexity and acuity, there is a clear need for efficient, highly coordinated care. These changes highlight opportunities for hepatology MDCs in alcohol-associated liver disease, metabolic dysfunctionāassociated steatotic liver disease, and palliative care. This review provides practical advice in navigating the complex logistics of establishing and maintaining a hepatology MDC while also reviewing the emerging evidence on clinical outcomes for patients seen in these MDCs. As hepatology looks to the future, establishment of MDCs in key clinical areas will be the cornerstone of patient care.
- 30 July 2024
- Published byĀ Wolters Kluwer HealthĀ inĀ Hepatology
- Vol.Ā 83 Ā (5) , 1287-1302
The rise of multidisciplinary clinics in hepatology: A practical, how-to-guide, and review of the literature
Multidisciplinary clinics (MDCs) are gaining momentum throughout the medical field, having initially been pioneered in oncology clinics due to their inherent ability to streamline complex care and improve both patient outcomes and the patient care experience. Liver transplant and hepatobiliary tumor clinics are examples of established MDCs in hepatology. With the changing landscape of liver disease in regard to etiology and patient complexity and acuity, there is a clear need for efficient, highly coordinated care. These changes highlight opportunities for hepatology MDCs in alcohol-associated liver disease, metabolic dysfunctionāassociated steatotic liver disease, and palliative care. This review provides practical advice in navigating the complex logistics of establishing and maintaining a hepatology MDC while also reviewing the emerging evidence on clinical outcomes for patients seen in these MDCs. As hepatology looks to the future, establishment of MDCs in key clinical areas will be the cornerstone of patient care.